<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04206280</url>
  </required_header>
  <id_info>
    <org_study_id>IRB19-096</org_study_id>
    <nct_id>NCT04206280</nct_id>
  </id_info>
  <brief_title>Use of Pedometer Following Radical Prostatectomy</brief_title>
  <official_title>Does the Use of a Post-Operative Pedometer Affect Rate of Return of Bowel Function and Narcotic Use Following Laparoscopic Robot Assisted Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benaroya Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virginia Mason Hospital/Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Benaroya Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to evaluate whether use of a pedometer following radical prostatectomy
      decreases post-operative narcotic use and time to return of bowel function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled prospective study looking at the effect of using a pedometer
      with graduated step-count goals following radical prostatectomy on return of bowel function
      and post-operative narcotic use. Subjects will be randomized into a control group or study
      group. The control group will receive standard of care, with information provided regarding
      the importance of ambulation following surgery. The study group will receive a pedometer with
      graduated step-count goals from post-operative day 0 to post-operative day 14. Both groups
      will be given a standardized post-operative narcotic regimen, and will be asked to record
      initial passage of flatus and first bowel movement. Subjects will remain on the study until
      initial post-operative visit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative narcotic use</measure>
    <time_frame>7-14 days</time_frame>
    <description>Morphine equivalents used following radical prostatectomy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of return of bowel function</measure>
    <time_frame>7-14 days</time_frame>
    <description>First passage of flatus and first bowel movement following surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Ambulation Difficulty</condition>
  <arm_group>
    <arm_group_label>Pedometer group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will be given a pedometer following radical prostatectomy. Subjects in the experimental group will have a graduated step-count goal as follows: POD 0-2: 2,000/day. POD 3-6: 3,000/day. POD 7-9: 4,000/day. POD 10-14: 5,000/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This is the control group. Following radical prostatectomy, subjects in the control group will receive standard of care, which includes counseling regarding the importance of ambulation following surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Use of a pedometer following surgery</intervention_name>
    <description>Subjects in the study group will receive a pedometer with graduated step count goals as discussed in arm description.</description>
    <arm_group_label>Pedometer group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Subjects in the control group will be counseled on the importance of ambulation during their pre-operative visit.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        This study will include men 18-75 undergoing robot-assisted laparoscopic radical
        prostatectomy for prostate cancer at Virginia Mason Medical Center.

        Exclusion Criteria:

          -  Long-term opioid use, defined by CDC as use of opioids on most days for &gt;3 months

          -  History of inflammatory bowel disease

          -  Prior abdominopelvic radiation

          -  Travel to Europe during study period

          -  Concurrent surgery during radical prostatectomy

          -  Inability to ambulate

          -  Gastroparesis or other baseline bowel dysmotility issues

          -  Inability or unwillingness of subject or legal guardian/representative to give written
             informed consent.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Corman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Mason Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Basil Ferenczi, MD</last_name>
    <phone>206-223-6600</phone>
    <email>basil.ferenczi@virginiamason.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Basil Ferenczi, MD</last_name>
      <phone>206-223-6772</phone>
      <email>basil.ferenczi@virginiamason.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 18, 2019</study_first_submitted>
  <study_first_submitted_qc>December 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>radical prostatectomy</keyword>
  <keyword>pedometer</keyword>
  <keyword>return of bowel function</keyword>
  <keyword>post-operative narcotic use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mobility Limitation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

